serine has been researched along with dasatinib in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ahmed, AA; Bast, RC; Claret, FX; He, G; Hung, MC; Le, XF; Mao, W; Siddik, ZH; Xia, W | 1 |
Asa, SL; Ezzat, S; Mayr, T; Tateno, T; Ullrich, A; Zheng, L | 1 |
Brzozowski, JS; Dun, MD; Humphrey, SJ; Kahl, RGS; Miller, K; Murray, HC; Smith, ND; Verrills, NM | 1 |
3 other study(ies) available for serine and dasatinib
Article | Year |
---|---|
The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Confounding Factors, Epidemiologic; Cyclin-Dependent Kinase Inhibitor p27; Dasatinib; Drug Synergism; Female; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Genes, bcl-1; Humans; Immunoblotting; Immunoprecipitation; In Situ Nick-End Labeling; Mice; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; Research Design; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Serine; src-Family Kinases; Thiazoles; Threonine; Tyrosine; Xenograft Model Antitumor Assays | 2011 |
The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis.
Topics: Animals; Cell Transformation, Neoplastic; Dasatinib; Gene Expression Regulation, Neoplastic; Gene Knock-In Techniques; Genes, src; Growth Hormone; Humans; Mice; Mitochondria; Phosphorylation; Pituitary Neoplasms; Polymorphism, Single Nucleotide; Prolactin; Pyrimidines; Rats; Receptor, Fibroblast Growth Factor, Type 4; Serine; STAT3 Transcription Factor; Thiazoles | 2011 |
Synergistic Targeting of DNA-PK and KIT Signaling Pathways in KIT Mutant Acute Myeloid Leukemia.
Topics: Animals; Apoptosis; Cell Line, Tumor; Dasatinib; DNA; DNA-Activated Protein Kinase; Leukemia, Myeloid, Acute; Mice; Mutation; Protein Kinase Inhibitors; Receptor Protein-Tyrosine Kinases; Serine; Signal Transduction; Threonine; TOR Serine-Threonine Kinases; Tyrosine | 2023 |